<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="1589">
  <stage>Registered</stage>
  <submitdate>5/06/2007</submitdate>
  <approvaldate>5/06/2007</approvaldate>
  <nctid>NCT00483808</nctid>
  <trial_identification>
    <studytitle>Renal Denervation in Patients With Refractory Hypertension</studytitle>
    <scientifictitle>Renal Denervation in Patients With Refractory Hypertension</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>TP-015 &amp; TP-038</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Hypertension</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Hypertension</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - Ardian Symplicity Catheter

Experimental: Denervation - Renal denervation using the Symplicty Catheter


Treatment: devices: Ardian Symplicity Catheter
Renal denervation using the Symplicity Catheter

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To provide confirmation that renal denervation is safe and feasible.</outcome>
      <timepoint>3 years</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Evidence of renal denervation; indication of physiologic response; assessment of device performance.</outcome>
      <timepoint>3 years</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  &gt;= 18 years of age.

          -  a systolic blood pressure of 160 mmHg or greater.

          -  receiving and adhering to full doses of an appropriate antihypertensive drug regimen
             for a minimum of two weeks prior to screening.

          -  agrees to have the study procedure(s) performed and additional procedures and
             evaluations, including repeat phlebotomy, imaging, urine analyses, and clinical
             examination.

          -  competent and willing to provide written, informed consent to participate in this
             clinical study.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  renal arterial abnormalities

          -  end stage renal disease requiring dialysis or renal transplant

          -  serum Cr &gt; 3, or calculated GFR &lt; 45 ml/min

          -  has experienced MI, unstable angina pectoris, or CVA with 6 months

          -  others</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate />
    <actualstartdate>1/06/2007</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>73</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/05/2013</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>St. Vincent's Hospital - Fitzroy</hospital>
    <hospital>The Alfred Hospital - Melbourne</hospital>
    <postcode>3065 - Fitzroy</postcode>
    <postcode>3004 - Melbourne</postcode>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Krakow</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Medtronic Vascular</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>To investigate the clinical utility of renal denervation in the treatment of refractory
      hypertension.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00483808</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Henry Krum, MBBS,PhD</name>
      <address>The Alfred Hospital and Monash University, Melbourne, VIC, Australia</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>